Redwood City, CA, United States of America

Jennifer Pitzen

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 7.3

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Fremont, CA (US) (2023)
  • Redwood City, CA (US) (2021 - 2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Jennifer Pitzen

Introduction

Jennifer Pitzen is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for various proteins involved in cancer treatment. With a total of 10 patents to her name, her work is recognized for its potential impact on medical science.

Latest Patents

Among her latest patents, Jennifer has developed substituted pyrazolopyrazines, imidazopyrazines, and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors. This innovation is directed towards creating effective inhibitors of SHP2, which play a crucial role in cancer progression. Additionally, she has worked on macrocyclic compounds that inhibit Ras proteins, along with their pharmaceutical compositions and protein complexes, aimed at treating various cancers.

Career Highlights

Jennifer Pitzen is currently employed at Revolution Medicines, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in pushing the boundaries of cancer treatment options, showcasing her dedication to improving patient outcomes.

Collaborations

Jennifer has collaborated with notable colleagues, including Adrian L Gill and G Leslie Burnett, to further enhance her research initiatives. These collaborations have allowed for a more comprehensive approach to tackling complex medical challenges.

Conclusion

Jennifer Pitzen's innovative work in the field of pharmaceuticals highlights her commitment to advancing cancer treatment through her patented inventions. Her contributions are paving the way for new therapeutic options that could significantly benefit patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…